<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Neurosurgery Blog &#187; hydrocephalus</title>
	<atom:link href="http://www.neurosurgery-blog.com/archives/tag/hydrocephalus/feed" rel="self" type="application/rss+xml" />
	<link>http://www.neurosurgery-blog.com</link>
	<description>Daily bibliographic and video review of the Neurosurgery Department. La Fe University Hospital. Valencia, Spain</description>
	<lastBuildDate>Thu, 09 Feb 2012 23:00:45 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.1</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>More malfunctioning Medos Hakim programmable valves: cause for concern?</title>
		<link>http://www.neurosurgery-blog.com/archives/3459</link>
		<comments>http://www.neurosurgery-blog.com/archives/3459#comments</comments>
		<pubDate>Mon, 28 Nov 2011 23:00:44 +0000</pubDate>
		<dc:creator>cba</dc:creator>
				<category><![CDATA[complications]]></category>
		<category><![CDATA[hydrocephalus]]></category>
		<category><![CDATA[malfunction]]></category>
		<category><![CDATA[Medos Hakim programmable valve]]></category>
		<category><![CDATA[shunt]]></category>

		<guid isPermaLink="false">http://www.neurosurgery-blog.com/?p=3459</guid>
		<description><![CDATA[J Neurosurg 115:1047–1052, 2011. DOI: 10.3171/2011.5.JNS101396
In recent years, the authors have noticed a growing number of programmable valve defects at their institution. Therefore, they conducted this study to evaluate the increased incidence of malfunctioning valves.
Methods. They investigated all revisions that had been performed at their institution between 1994 and 2010 for dislodgement of the stator [...]]]></description>
			<content:encoded><![CDATA[<p><strong><a href="http://www.neurosurgery-blog.com/wp-content/uploads/2011/11/statordislodgement.jpg"><img class="alignleft size-thumbnail wp-image-3462" title="statordislodgement" src="http://www.neurosurgery-blog.com/wp-content/uploads/2011/11/statordislodgement-150x150.jpg" alt="" width="150" height="150" /></a>J Neurosurg 115:1047–1052, 2011. DOI: 10.3171/2011.5.JNS101396</strong></p>
<p style="text-align: justify;">In recent years, the authors have noticed a growing number of programmable valve defects at their institution. Therefore, they conducted this study to evaluate the increased incidence of malfunctioning valves.</p>
<p style="text-align: justify;">Methods. They investigated all revisions that had been performed at their institution between 1994 and 2010 for dislodgement of the stator of a standard Medos Hakim programmable valve with a prechamber.</p>
<p style="text-align: justify;">Results. Fifteen valves were removed because of dislodged stators. The valves had been implanted between May 16, 1993, and December 27, 2002, and were explanted between February 19, 2006, and January 22, 2010. Thus, the valves had been in place for a mean period of 11 years (median 11 years, range 7–14 years). The percentage of dislodged stators was almost 3% (15 of 546 valves). Particularly noteworthy is that all malfunctioning valves were found in children who had been younger than 1 year of age at the time of implantation.</p>
<p style="text-align: justify;">Conclusions. Medos Hakim programmable valve malfunctions are rare events but should receive careful attention. When the pressure setting cannot be adjusted, a malfunction should always be suspected and radiographic imaging should be performed to assess the valve. Stator dislodgement is the most serious form of valve adjustment failure.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.neurosurgery-blog.com/archives/3459/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Management of Adult Hydrocephalus With Ventriculoperitoneal Shunts: Long-term Single- Institution Experience</title>
		<link>http://www.neurosurgery-blog.com/archives/3227</link>
		<comments>http://www.neurosurgery-blog.com/archives/3227#comments</comments>
		<pubDate>Tue, 04 Oct 2011 22:00:40 +0000</pubDate>
		<dc:creator>cba</dc:creator>
				<category><![CDATA[complications]]></category>
		<category><![CDATA[hydrocephalus]]></category>
		<category><![CDATA[Cerebrospinal fluid shunts]]></category>
		<category><![CDATA[Shunt complication]]></category>
		<category><![CDATA[Shunt failure]]></category>
		<category><![CDATA[shunt revisión]]></category>
		<category><![CDATA[Shunt surgery]]></category>
		<category><![CDATA[Ventriculoperitoneal shunting]]></category>

		<guid isPermaLink="false">http://www.neurosurgery-blog.com/?p=3227</guid>
		<description><![CDATA[Neurosurgery 69:774–781, 2011 DOI: 10.1227/NEU.0b013e31821ffa9e
Ventriculoperitoneal shunting is the most widely used neurosurgical procedure for the management of hydrocephalus.
OBJECTIVE: To evaluate our long-term single-institution experience in the management of adult hydrocephalus patients with ventriculoperitoneal shunts.
METHODS: Adult patients who underwent ventriculoperitoneal shunt placement for hydrocephalus from October 1990 to October 2009 were included. Medical charts, operative reports, [...]]]></description>
			<content:encoded><![CDATA[<p><strong><a href="http://www.neurosurgery-blog.com/wp-content/uploads/2011/10/hydrocephalus.gif"><img class="alignleft size-thumbnail wp-image-3231" title="hydrocephalus" src="http://www.neurosurgery-blog.com/wp-content/uploads/2011/10/hydrocephalus-150x150.gif" alt="" width="150" height="150" /></a>Neurosurgery 69:774–781, 2011 DOI: 10.1227/NEU.0b013e31821ffa9e</strong></p>
<p style="text-align: justify;">Ventriculoperitoneal shunting is the most widely used neurosurgical procedure for the management of hydrocephalus.</p>
<p style="text-align: justify;">OBJECTIVE: To evaluate our long-term single-institution experience in the management of adult hydrocephalus patients with ventriculoperitoneal shunts.</p>
<p style="text-align: justify;">METHODS: Adult patients who underwent ventriculoperitoneal shunt placement for hydrocephalus from October 1990 to October 2009 were included. Medical charts, operative reports, imaging studies, and clinical follow-up evaluations were reviewed and analyzed retrospectively for clinical outcome in adult hydrocephalus patients.</p>
<p style="text-align: justify;">RESULTS: A total of 683 adult patients were included in the study. The most common etiologies of hydrocephalus include idiopathic (29%), tumors and cysts (20%), postcraniotomy (13%), and subarachnoid hemorrhage (13%). The overall shunt failure rate was 32%, and the majority (74%) of shunt revisions occurred within the first 6 months. The median time to first shunt revision was 9.31 months. Etiology of hydrocephalus showed a significant impact on the incidence of shunt revision/failure and on the median time to shunt revision. Similarly, the type of hydrocephalus had a significant effect on the incidence of shunt failure and the median time to shunt revision.</p>
<p style="text-align: justify;">CONCLUSION: A large proportion of patients (32%) experience shunt failure after shunt placement for hydrocephalus. Although the overall incidence of shunt revision was comparable to previously reported studies, the fact that a large proportion of adult populations with shunt placement experience shunt failure is a concern.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.neurosurgery-blog.com/archives/3227/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Effect of Antibiotic-Impregnated Shunts on Infection Rate in Adult Hydrocephalus: A Single Institution’s Experience</title>
		<link>http://www.neurosurgery-blog.com/archives/3148</link>
		<comments>http://www.neurosurgery-blog.com/archives/3148#comments</comments>
		<pubDate>Tue, 13 Sep 2011 22:00:54 +0000</pubDate>
		<dc:creator>cba</dc:creator>
				<category><![CDATA[Infections]]></category>
		<category><![CDATA[hydrocephalus]]></category>
		<category><![CDATA[Antibiotic-impregnated shunts]]></category>

		<guid isPermaLink="false">http://www.neurosurgery-blog.com/?p=3148</guid>
		<description><![CDATA[Neurosurgery 69:625–629, 2011 DOI: 10.1227/NEU.0b013e31821bc435
Cerebrospinal fluid (CSF) shunt infection remains a major cause of morbidity and mortality in the treatment of hydrocephalus. Studies have demonstrated the efficacy of antibiotic-impregnated shunt (AIS) systems in reducing CSF shunt infections in pediatric patients. Fewer studies evaluate the efficacy of AIS systems in adult hydrocephalus.
OBJECTIVE: To determine whether categorical [...]]]></description>
			<content:encoded><![CDATA[<p><strong><a href="http://www.neurosurgery-blog.com/wp-content/uploads/2011/09/bactiseal2.jpg"><img class="alignleft size-thumbnail wp-image-3151" title="bactiseal2" src="http://www.neurosurgery-blog.com/wp-content/uploads/2011/09/bactiseal2-150x134.jpg" alt="" width="150" height="134" /></a>Neurosurgery 69:625–629, 2011 DOI: 10.1227/NEU.0b013e31821bc435</strong></p>
<p style="text-align: justify;">Cerebrospinal fluid (CSF) shunt infection remains a major cause of morbidity and mortality in the treatment of hydrocephalus. Studies have demonstrated the efficacy of antibiotic-impregnated shunt (AIS) systems in reducing CSF shunt infections in pediatric patients. Fewer studies evaluate the efficacy of AIS systems in adult hydrocephalus.</p>
<p style="text-align: justify;">OBJECTIVE: To determine whether categorical conversion to AIS shunt systems reduced the incidence of shunt infection in adults.</p>
<p style="text-align: justify;">METHODS: All adult patients undergoing CSF shunt insertion over a 7-year period were retrospectively reviewed (2004-2009). In 2006, a categorical switch to AIS catheters was made. Before 2006, standard nonimpregnated shunt catheters were used. We retrospectively reviewed the first 250 cases of AIS catheter implantation and compared them with the immediately preceding 250 non-AIS cases to assess 1-year incidence of CSF shunt infection.</p>
<p style="text-align: justify;">RESULTS: Five hundred shunt surgeries were performed for normal-pressure hydrocephalus in 378 patients (76%), pseudotumor cerebri in 83 patients (17%), and various obstructive/communicating hydrocephalus etiologies in 40 patients (8%). All patients were followed for 12 months. The mean age was 60 6 18 years. Baseline characteristics were similar between AIS (n = 250) and non-AIS (n = 250) cohorts. Overall, 13 patients (2.6%) experienced CSF shunt infection, occurring a mean of 2 6 2 months postoperatively. Shunt infection incidence was decreased in AIS (1.2%) vs non-AIS (4.0%) cohorts (P = .0492). Staphylococcus epidermidis was the most common pathogen in AIS and non-AIS cohorts. Oxacillin resistance was not increased in the AIS cohort.</p>
<p style="text-align: justify;">CONCLUSION: Categorical conversion to AIS catheters was associated with a reduced incidence of shunt infection. AIS catheters may be a reliable instrument for decreasing perioperative shunt colonization and subsequent infection in adults with hydrocephalus.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.neurosurgery-blog.com/archives/3148/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Laparoscopic versus open insertion of the peritoneal catheter in ventriculoperitoneal shunt placement: review of 810 consecutive cases</title>
		<link>http://www.neurosurgery-blog.com/archives/2946</link>
		<comments>http://www.neurosurgery-blog.com/archives/2946#comments</comments>
		<pubDate>Thu, 28 Jul 2011 22:00:59 +0000</pubDate>
		<dc:creator>cba</dc:creator>
				<category><![CDATA[Endoscopy]]></category>
		<category><![CDATA[Surgical technique]]></category>
		<category><![CDATA[hydrocephalus]]></category>
		<category><![CDATA[complications]]></category>
		<category><![CDATA[Laparoscopy]]></category>
		<category><![CDATA[minilaparotomy]]></category>
		<category><![CDATA[Shunt failure]]></category>
		<category><![CDATA[Ventriculoperitoneal shunt]]></category>

		<guid isPermaLink="false">http://www.neurosurgery-blog.com/?p=2946</guid>
		<description><![CDATA[J Neurosurg 115:151–158, 2011. DOI: 10.3171/2011.1.JNS101492
Traditional ventriculoperitoneal (VP) shunt surgery involves insertion of the distal catheter by minilaparotomy. However, minilaparotomy may be a significant source of morbidity during shunt surgery. Laparoscopic insertion of the distal catheter is an alternative technique that may simplify and improve the safety of shunt surgery.
Methods. The authors performed a retrospective [...]]]></description>
			<content:encoded><![CDATA[<p><strong><a href="http://www.neurosurgery-blog.com/wp-content/uploads/2011/07/laparoscopic.jpg"><img class="alignleft size-thumbnail wp-image-2948" title="laparoscopic" src="http://www.neurosurgery-blog.com/wp-content/uploads/2011/07/laparoscopic-150x150.jpg" alt="" width="150" height="150" /></a>J Neurosurg 115:151–158, 2011. DOI: 10.3171/2011.1.JNS101492</strong></p>
<p style="text-align: justify;">Traditional ventriculoperitoneal (VP) shunt surgery involves insertion of the distal catheter by minilaparotomy. However, minilaparotomy may be a significant source of morbidity during shunt surgery. Laparoscopic insertion of the distal catheter is an alternative technique that may simplify and improve the safety of shunt surgery.</p>
<p style="text-align: justify;">Methods. The authors performed a retrospective review of hospital records of all patients undergoing new VP shunt insertion at a tertiary care center between 2004 and 2009. Patient characteristics and outcomes were compared between patients undergoing open or laparoscopic insertion of the distal catheter. Independent variables in the analysis included age, sex, race, body mass index, surgical technique, previous VP shunt placement, previous abdominal procedures, American Society of Anesthesiology (ASA) score, and indication for shunt placement. Dependent variables included the occurrence of shunt failure, cause of shunt failure, complications, length of stay (LOS), LOS after shunt placement, estimated blood loss, and operative time.</p>
<p style="text-align: justify;">Results. The authors identified 810 patients who met the inclusion criteria; open or laparoscopic distal catheter insertion was performed in 335 and 475 patients, respectively. There were no significant differences between the groups regarding age, race, ASA score, or indication for shunt placement. The most common indication was hydrocephalus due to subarachnoid hemorrhage, followed by tumor-associated hydrocephalus, normal pressure hydrocephalus (NPH), and hydrocephalus due to trauma. The incidence of shunt failure was not statistically different between cohorts, occurring in 20.0% of laparoscopic and 20.9% of open catheter placement cases (p = 0.791). With analysis of causes of shunt failure, shunt obstruction occurred significantly more often in the open surgery cohort (p = 0.012). In patients with a known cause shunt obstruction, distal obstruction occurred in 35.7% of the open cohort obstructions and 4.8% of the laparoscopic cohort obstructions (p = 0.014). The relative risk of distal obstruction in open cases compared with laparoscopic cases was 7.50. Infections occurred in 8.2% of laparoscopic cases compared with 6.6% of open cases (p = 0.419). Within the NPH subgroup, the laparoscopically treated patients had significantly more overdrainage (p = 0.040), whereas those in the open cohort experienced significantly more shunt obstructions (p = 0.034). Laparoscopically treated patients had shorter operative times (p &lt; 0.0005), inpatient LOS (p &lt; 0.001), and inpatient LOS after VP shunt placement (p = 0.01) as well as less blood loss (p = 0.058).</p>
<p style="text-align: justify;">Conclusions. To our knowledge this is the largest reported comparison of distal VP shunt catheter insertion techniques. Compared with minilaparotomy, the laparoscopic approach was associated with decreased time in the operating room and a decreased LOS. Moreover, laparoscopy was associated with fewer distal shunt obstructions. Laparoscopic shunt surgery is a viable alternative to traditional shunt surgery.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.neurosurgery-blog.com/archives/2946/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>A standardized protocol to reduce cerebrospinal fluid shunt infection: The Hydrocephalus Clinical Research Network Quality Improvement Initiative</title>
		<link>http://www.neurosurgery-blog.com/archives/2919</link>
		<comments>http://www.neurosurgery-blog.com/archives/2919#comments</comments>
		<pubDate>Thu, 21 Jul 2011 22:00:55 +0000</pubDate>
		<dc:creator>cba</dc:creator>
				<category><![CDATA[Clinical Guide]]></category>
		<category><![CDATA[Infections]]></category>
		<category><![CDATA[hydrocephalus]]></category>
		<category><![CDATA[Infection]]></category>
		<category><![CDATA[quality improvement]]></category>
		<category><![CDATA[shunt]]></category>
		<category><![CDATA[standardized protocol]]></category>

		<guid isPermaLink="false">http://www.neurosurgery-blog.com/?p=2919</guid>
		<description><![CDATA[J Neurosurg Pediatrics 8:22–29, 2011. DOI: 10.3171/2011.4.PEDS10551
Quality improvement techniques are being implemented in many areas of medicine. In an effort to reduce the ventriculoperitoneal shunt infection rate, a standardized protocol was developed and implemented at 4 centers of the Hydrocephalus Clinical Research Network (HCRN).
Methods. The protocol was developed sequentially by HCRN members using the current [...]]]></description>
			<content:encoded><![CDATA[<p><strong><a href="http://www.neurosurgery-blog.com/wp-content/uploads/2011/07/A-standardized-protocol-to-reduce-cerebrospinal-fluid-shunt-infection-The-Hydrocephalus-Clinical-Research-Network-Quality-Improvement-Initiative.jpg"><img class="alignleft size-thumbnail wp-image-2923" title="A standardized protocol to reduce cerebrospinal fluid shunt infection- The Hydrocephalus Clinical Research Network Quality Improvement Initiative" src="http://www.neurosurgery-blog.com/wp-content/uploads/2011/07/A-standardized-protocol-to-reduce-cerebrospinal-fluid-shunt-infection-The-Hydrocephalus-Clinical-Research-Network-Quality-Improvement-Initiative-150x150.jpg" alt="" width="150" height="150" /></a>J Neurosurg Pediatrics 8:22–29, 2011. DOI: 10.3171/2011.4.PEDS10551</strong></p>
<p style="text-align: justify;">Quality improvement techniques are being implemented in many areas of medicine. In an effort to reduce the ventriculoperitoneal shunt infection rate, a standardized protocol was developed and implemented at 4 centers of the Hydrocephalus Clinical Research Network (HCRN).</p>
<p style="text-align: justify;">Methods. The protocol was developed sequentially by HCRN members using the current literature and prior institutional experience until consensus was obtained. The protocol was prospectively applied at each HCRN center to all children undergoing a shunt insertion or revision procedure. Infections were defined on the basis of CSF, wound, or pseudocyst cultures; wound breakdown; abdominal pseudocyst; or positive blood cultures in the presence of a ventriculoatrial shunt. Procedures and infections were measured before and after protocol implementation.</p>
<p style="text-align: justify;">Results. Twenty-one surgeons at 4 centers performed 1571 procedures between June 1, 2007, and February 28, 2009. The minimum follow-up was 6 months. The Network infection rate decreased from 8.8% prior to the protocol to 5.7% while using the protocol (p = 0.0028, absolute risk reduction 3.15%, relative risk reduction 36%). Three of 4 centers lowered their infection rate. Shunt surgery after external ventricular drainage (with or without prior infection) had the highest infection rate. Overall protocol compliance was 74.5% and improved over the course of the observation period. Based on logistic regression analysis, the use of BioGlide catheters (odds ratio [OR] 1.91, 95% CI 1.19–3.05; p = 0.007) and the use of antiseptic cream by any members of the surgical team (instead of a formal surgical scrub by all members of the surgical team; OR 4.53, 95% CI 1.43–14.41; p = 0.01) were associated with an increased risk of infection.</p>
<p style="text-align: justify;">Conclusions. The standardized protocol for shunt surgery significantly reduced shunt infection across the HCRN. Overall protocol compliance was good. The protocol has established a common baseline within the Network, which will facilitate assessment of new treatments. Identification of factors associated with infection will allow further protocol refinement in the future.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.neurosurgery-blog.com/archives/2919/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Laparoscopy-assisted ventriculoperitoneal shunt surgery: personal experience and review of the literature</title>
		<link>http://www.neurosurgery-blog.com/archives/2880</link>
		<comments>http://www.neurosurgery-blog.com/archives/2880#comments</comments>
		<pubDate>Tue, 12 Jul 2011 22:00:29 +0000</pubDate>
		<dc:creator>cba</dc:creator>
				<category><![CDATA[Surgical technique]]></category>
		<category><![CDATA[hydrocephalus]]></category>
		<category><![CDATA[Laparoscopy]]></category>
		<category><![CDATA[Minimal access]]></category>
		<category><![CDATA[Ventriculoperitoneal shunt]]></category>
		<category><![CDATA[Ventriculoperitoneal shunt revision]]></category>

		<guid isPermaLink="false">http://www.neurosurgery-blog.com/?p=2880</guid>
		<description><![CDATA[Neurosurg Rev (2011) 34:363–371. DOI 10.1007/s10143-011-0309-6
Ventriculoperitoneal shunting is a widely accepted technique for the treatment of hydrocephalus. The standard procedure to insert the peritoneal catheter requires an abdominal incision, muscle dissection, and opening of the peritoneum. A number of complications related to the abdominal surgical phase have been reported. Laparoscopy-assisted ventriculoperitoneal shunting is a valid [...]]]></description>
			<content:encoded><![CDATA[<p><strong><a href="http://www.neurosurgery-blog.com/wp-content/uploads/2011/07/Laparoscopy-assisted-ventriculoperitoneal-shunt-surgery.jpg"><img class="alignleft size-thumbnail wp-image-2881" title="Laparoscopy-assisted ventriculoperitoneal shunt surgery" src="http://www.neurosurgery-blog.com/wp-content/uploads/2011/07/Laparoscopy-assisted-ventriculoperitoneal-shunt-surgery-150x150.jpg" alt="" width="150" height="150" /></a>Neurosurg Rev (2011) 34:363–371. DOI 10.1007/s10143-011-0309-6</strong></p>
<p style="text-align: justify;">Ventriculoperitoneal shunting is a widely accepted technique for the treatment of hydrocephalus. The standard procedure to insert the peritoneal catheter requires an abdominal incision, muscle dissection, and opening of the peritoneum. A number of complications related to the abdominal surgical phase have been reported. Laparoscopy-assisted ventriculoperitoneal shunting is a valid alternative procedure that reduces surgical trauma.</p>
<p style="text-align: justify;">We describe our experience and review the literature. A total of 30 laparoscopically guided ventriculoperitoneal shunting procedures were performed between January 2007 and June 2008, in collaboration with a general surgeon experienced in laparoscopy. Of these procedures, 25 were new shunt placements and 5 were revisions. Data about operative time, outcome, and complications were registered and compared with a group of 30 patients treated by means of standard laparotomy in the period 2005–2007. Laparoscopic shunt placement was successful in all patients. Operative duration, complications, and postoperative pain were all lower in patients treated by laparoscopy as compared to the laparotomy. In the laparoscopic group, an earlier peristalsis, quicker mobilization, and better cosmetic results were also noted.</p>
<p style="text-align: justify;">Laparoscopy in both ventriculoperitoneal shunt placement and revision is a safe, effective, and minimally invasive technique. It ensures proper abdominal placement of the distal catheter under direct vision allowing confirmation of its patency.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.neurosurgery-blog.com/archives/2880/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Diffusion Tensor Imaging Reveals Supplementary Lesions to Frontal White Matter in Idiopathic Normal Pressure Hydrocephalus</title>
		<link>http://www.neurosurgery-blog.com/archives/2799</link>
		<comments>http://www.neurosurgery-blog.com/archives/2799#comments</comments>
		<pubDate>Wed, 22 Jun 2011 22:00:04 +0000</pubDate>
		<dc:creator>cba</dc:creator>
				<category><![CDATA[hydrocephalus]]></category>
		<category><![CDATA[CSF drainage]]></category>
		<category><![CDATA[Diffusion]]></category>
		<category><![CDATA[MRI]]></category>
		<category><![CDATA[White matter]]></category>

		<guid isPermaLink="false">http://www.neurosurgery-blog.com/?p=2799</guid>
		<description><![CDATA[Neurosurgery 68:1586–1593, 2011 DOI: 10.1227/NEU.0b013e31820f3401
Idiopathic normal-pressure hydrocephalus (INPH) is associated with white matter lesions, but the extent and severity of the lesions do not cohere with symptoms or improvement after shunting, implying the presence of further, yet undisclosed, injuries to white matter in INPH.
OBJECTIVE: To apply diffusion tensor imaging (DTI) to explore white matter lesions [...]]]></description>
			<content:encoded><![CDATA[<p><strong><a href="http://www.neurosurgery-blog.com/wp-content/uploads/2011/06/Diffusion_Tensor_Imaging_Reveals_Supplementary.tiff"><img class="alignleft size-full wp-image-2801" title="Diffusion_Tensor_Imaging_Reveals_Supplementary" src="http://www.neurosurgery-blog.com/wp-content/uploads/2011/06/Diffusion_Tensor_Imaging_Reveals_Supplementary.tiff" alt="" width="184" height="267" /></a>Neurosurgery 68:1586–1593, 2011 DOI: 10.1227/NEU.0b013e31820f3401</strong></p>
<p style="text-align: justify;">Idiopathic normal-pressure hydrocephalus (INPH) is associated with white matter lesions, but the extent and severity of the lesions do not cohere with symptoms or improvement after shunting, implying the presence of further, yet undisclosed, injuries to white matter in INPH.</p>
<p style="text-align: justify;">OBJECTIVE: To apply diffusion tensor imaging (DTI) to explore white matter lesions in patients with INPH before and after drainage of cerebrospinal fluid (CSF).</p>
<p style="text-align: justify;">METHODS: Eighteen patients and 10 controls were included. DTI was performed in a 1.5T MRI scanner before and after 3-day drainage of 400 mL of CSF. Regions of interest included corpus callosum, capsula interna, frontal and lateral periventricular white matter, and centrum semiovale. White matter integrity was quantified by assessing fractional anisotropies (FA) and apparent diffusion coefficients (ADC), comparing them between patients and controls and between patients before and after drainage. The significance level corresponded to .05 (Bonferroni corrected).</p>
<p style="text-align: justify;">RESULTS: Decreased FA in patients was found in 3 regions (P &lt; .002, P &lt; .001, and P &lt; .001) in anterior frontal white matter, whereas elevated ADC was found in genu corpus callosum (P &lt; .001) and areas of centrum semiovale associated with the precentral gyri (P &lt; .002). Diffusion patterns in these areas did not change after drainage.</p>
<p style="text-align: justify;">CONCLUSION: DTI reveals subtle injuries—interpreted as axonal loss and gliosis—to anterior frontal white matter where high-order motor systems between frontal cortex and basal ganglia travel, further supporting the notion that motor symptoms in INPH are caused by a chronic ischemia to the neuronal systems involved in the planning processes of movements.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.neurosurgery-blog.com/archives/2799/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Use of 5-ALA fluorescence guided endoscopic biopsy of a deep-seated primary malignant brain tumor</title>
		<link>http://www.neurosurgery-blog.com/archives/2697</link>
		<comments>http://www.neurosurgery-blog.com/archives/2697#comments</comments>
		<pubDate>Sun, 29 May 2011 22:00:00 +0000</pubDate>
		<dc:creator>cba</dc:creator>
				<category><![CDATA[Endoscopy]]></category>
		<category><![CDATA[Oncology]]></category>
		<category><![CDATA[Surgical technique]]></category>
		<category><![CDATA[5-aminolevulinic acid]]></category>
		<category><![CDATA[biopsy]]></category>
		<category><![CDATA[deep-seated glioma]]></category>
		<category><![CDATA[hydrocephalus]]></category>
		<category><![CDATA[photodynamic diagnosis]]></category>

		<guid isPermaLink="false">http://www.neurosurgery-blog.com/?p=2697</guid>
		<description><![CDATA[J Neurosurg 114:1410–1413, 2011. DOI: 10.3171/2010.11.JNS10250
The introduction of fluorescence-guided resection of primary malignant brain tumors was a milestone in neurosurgery. Deep-seated malignant brain tumors are often not approachable for microsurgical resection. For diagnosis and therapy, new strategies are recommended. The combination of endoscopy and 5-aminolevulinic acid–induced protoporphyrin IX (5-ALA-induced Pp IX) fluorescence–guided procedures supported by [...]]]></description>
			<content:encoded><![CDATA[<p><strong><a href="http://www.neurosurgery-blog.com/wp-content/uploads/2011/05/5ALA_deeptumor.png"><img class="alignleft size-thumbnail wp-image-2698" title="5ALA_deeptumor" src="http://www.neurosurgery-blog.com/wp-content/uploads/2011/05/5ALA_deeptumor-150x150.png" alt="" width="150" height="150" /></a>J Neurosurg 114:1410–1413, 2011. DOI: 10.3171/2010.11.JNS10250</strong></p>
<p style="text-align: justify;">The introduction of fluorescence-guided resection of primary malignant brain tumors was a milestone in neurosurgery. Deep-seated malignant brain tumors are often not approachable for microsurgical resection. For diagnosis and therapy, new strategies are recommended. The combination of endoscopy and 5-aminolevulinic acid–induced protoporphyrin IX (5-ALA-induced Pp IX) fluorescence–guided procedures supported by neuronavigation seems an interesting option. Here the authors report on a combined approach for 5-ALA fluorescence–guided biopsy in which they use an endoscopy system based on an Xe lamp (excitation approximately lambda = 407 nm; dichroic filter system lambda = 380–430 nm) to treat a malignant tumor of the thalamus and perform a ventriculostomy and septostomy. The excitation filter and emission filter are adapted to ensure that the remaining visible blue remission is sufficient to superimpose on or suppress the excited red fluorescence of the endogenous fluorochromes. The authors report that the lesion was easily detectable in the fluorescence mode and that biopsy led to histological diagnosis.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.neurosurgery-blog.com/archives/2697/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Hydrocephalus associated with vestibular schwannomas: management options and factors predicting the outcome</title>
		<link>http://www.neurosurgery-blog.com/archives/2588</link>
		<comments>http://www.neurosurgery-blog.com/archives/2588#comments</comments>
		<pubDate>Thu, 05 May 2011 04:00:38 +0000</pubDate>
		<dc:creator>cba</dc:creator>
				<category><![CDATA[Oncology]]></category>
		<category><![CDATA[hydrocephalus]]></category>
		<category><![CDATA[cerebellopontine angle]]></category>
		<category><![CDATA[prognostic factor]]></category>
		<category><![CDATA[Vestibular schwannoma]]></category>

		<guid isPermaLink="false">http://www.neurosurgery-blog.com/?p=2588</guid>
		<description><![CDATA[J Neurosurg 114:1209–1215, 2011. DOI: 10.3171/2010.10.JNS1029
The current, generally accepted optimal management for hydrocephalus related to vestibular schwannomas (VSs) is primary tumor removal, with further treatment reserved only for patients who remain symptomatic. Previous studies have shown, however, that this management can lead to an increase in surgery-related complications. In this study, the authors evaluated their [...]]]></description>
			<content:encoded><![CDATA[<p><strong><a href="http://www.neurosurgery-blog.com/wp-content/uploads/2011/05/VS+Hy.jpg"><img class="alignleft size-thumbnail wp-image-2589" title="VS+Hy" src="http://www.neurosurgery-blog.com/wp-content/uploads/2011/05/VS+Hy-150x150.jpg" alt="" width="150" height="150" /></a>J Neurosurg 114:1209–1215, 2011. DOI: 10.3171/2010.10.JNS1029</strong></p>
<p style="text-align: justify;">The current, generally accepted optimal management for hydrocephalus related to vestibular schwannomas (VSs) is primary tumor removal, with further treatment reserved only for patients who remain symptomatic. Previous studies have shown, however, that this management can lead to an increase in surgery-related complications. In this study, the authors evaluated their experience with the treatment of such patients, with the aim of identifying the following: 1) the parameters correlating to the need for specific hydrocephalus treatment following VS surgery; and 2) patients at risk for developing hydrocephalus-related complications.</p>
<p style="text-align: justify;">Methods. This was a retrospective study of a 400-patient series. The complication rates and outcomes following primary hydrocephalus treatment versus primary VS removal were compared. Patients undergoing primary tumor removal were further subdivided on the basis of the need for subsequent hydrocephalus treatment. The 3 categories of parameters tested for correlation with the need for such subsequent treatment as well as with heightened risk for developing complications were patient-, tumor-, and hydrocephalus-related.</p>
<p style="text-align: justify;">Results. Of the entire series, 53 patients presented with hydrocephalus. Forty-eight of 53 patients underwent primary VS surgery, of whom 42 (87.5%) did not require additional hydrocephalus treatment. Of the 6 patients who did require additional hydrocephalus treatment, only 3 ultimately required a VP shunt. Factors correlating to the need of hydrocephalus treatment after VS removal were large tumor size, irregular tumor surface, and severe preoperative hydrocephalus. Patients with a longer symptom duration prior to surgery, those with polycyclic tumors, or with inhomogeneous VS, were at heightened risk for the development of CSF leaks. The general and functional outcome of surgery showed no correlation to the presence of preoperative hydrocephalus.</p>
<p style="text-align: justify;">Conclusions. Primary tumor removal is the optimum management of disease in patients with VS with associated hydrocephalus; it leads to resolution of the hydrocephalus in the majority of cases, and the outcome is similar to that of patients without hydrocephalus. Certain factors may aid in identifying patients at risk for developing persistent hydrocephalus as well as those at risk for CSF leaks</p>
]]></content:encoded>
			<wfw:commentRss>http://www.neurosurgery-blog.com/archives/2588/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pineal region tumors: an optimal approach for simultaneous endoscopic third ventriculostomy and biopsy</title>
		<link>http://www.neurosurgery-blog.com/archives/2554</link>
		<comments>http://www.neurosurgery-blog.com/archives/2554#comments</comments>
		<pubDate>Thu, 28 Apr 2011 04:00:32 +0000</pubDate>
		<dc:creator>cba</dc:creator>
				<category><![CDATA[Endoscopy]]></category>
		<category><![CDATA[Oncology]]></category>
		<category><![CDATA[hydrocephalus]]></category>
		<category><![CDATA[biopsy]]></category>
		<category><![CDATA[Endoscopic Third Ventriculostomy]]></category>
		<category><![CDATA[Neuroendoscopy]]></category>
		<category><![CDATA[pineal gland]]></category>
		<category><![CDATA[pineal tumor]]></category>

		<guid isPermaLink="false">http://www.neurosurgery-blog.com/?p=2554</guid>
		<description><![CDATA[Neurosurg Focus 30 (4):E3, 2011. DOI: 10.3171/2011.2.FOCUS10301
Simultaneous endoscopic third ventriculostomy (ETV) and tumor biopsy is a widely accepted therapeutic and diagnostic procedure for patients with noncommunicating hydrocephalus secondary to a pineal region tumor. Multiple approaches have been advocated, including the use of a steerable fiberoptic or rigid lens endoscope via 1 or 2 trajectories. However, [...]]]></description>
			<content:encoded><![CDATA[<p><strong><a href="http://www.neurosurgery-blog.com/wp-content/uploads/2011/04/pineal_tumor.png"><img class="alignleft size-thumbnail wp-image-2556" title="pineal_tumor" src="http://www.neurosurgery-blog.com/wp-content/uploads/2011/04/pineal_tumor-150x150.png" alt="" width="150" height="150" /></a>Neurosurg Focus 30 (4):E3, 2011. DOI: 10.3171/2011.2.FOCUS10301</strong></p>
<p style="text-align: justify;">Simultaneous endoscopic third ventriculostomy (ETV) and tumor biopsy is a widely accepted therapeutic and diagnostic procedure for patients with noncommunicating hydrocephalus secondary to a pineal region tumor. Multiple approaches have been advocated, including the use of a steerable fiberoptic or rigid lens endoscope via 1 or 2 trajectories. However, the optimal approach has not been established based on the individual anatomical characteristics of the patient.</p>
<p style="text-align: justify;"> Methods. A retrospective review of patients undergoing simultaneous ETV and tumor biopsy was undertaken. Preoperative MR images were examined to measure the width of the anterior third ventricle and maximal diameters of the tumor, Monro foramen (right), and massa intermedia. The distances between the tumor and massa intermedia, tumor and anterior commissure, midbrain and massa intermedia, and the dorsum sella and anterior commissure were also recorded. Single and dual trajectory approaches were compared using paired t-tests for each parameter.</p>
<p style="text-align: justify;">Results. Over an 8-year interval, 15 patients underwent simultaneous ETV and tumor management. These patients ranged from 6 to 71 years of age (mean 36.7 years); 5 were younger than 18 years of age. Seven were treated using a dual trajectory approach, and 8 were treated using a single trajectory approach. All cases were completed without complications or the need for an additional CSF diversionary procedure within 6 months. The diagnostic yield at biopsy was 86.7%. There were no statistically significant differences between the single and dual trajectory groups for the measured parameters. However, the dual trajectory group demonstrated a larger anterior third ventricular diameter (1.43 vs 1.21 cm, p = 0.29). The single trajectory group trended toward a smaller tumor– anterior commissure interval (2.23 vs 2.51 cm, p = 0.24) and a larger dorsum sella–anterior commissure distance (1.67 vs 1.49 cm, p = 0.28).</p>
<p style="text-align: justify;">Conclusions. These data confirm the safety and diagnostic efficacy of simultaneous ETV and biopsy for tumors of the pineal region. Although no statistically significant differences were seen in the authors’ recorded measurements, several trends suggest a role for a tailored approach to selecting a single or dual trajectory approach when using a rigid endoscope</p>
]]></content:encoded>
			<wfw:commentRss>http://www.neurosurgery-blog.com/archives/2554/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

